ANTONY ROSEN, MD
Osteopathic Medicine at Wolfe St, Baltimore, MD

License number
Maryland D43998
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-3052
(410) 933-4397

Professional information

Antony Rosen Photo 1

Dr. Antony Rosen, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Rheumatology
Address:
MFL CTR TOWER
5200 Eastern Ave STE 4100, Baltimore 21224
(410) 550-2015 (Phone), (410) 550-2072 (Fax)
JOHNS HOPKINS UNIVERSITY HOSPITAL DEPARTMENT OF EMERGENCY
600 N Wolfe St STE 1159, Baltimore 21287
(410) 955-2280 (Phone), (410) 614-8751 (Fax)
Conditions:
Fibromyalgia, Systemic Lupus Erythematosus (SLE), Vasculitis
Certifications:
Internal Medicine, 1993, Rheumatology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MFL CTR TOWER
5200 Eastern Ave STE 4100, Baltimore 21224
JOHNS HOPKINS UNIVERSITY HOSPITAL DEPARTMENT OF EMERGENCY
600 N Wolfe St STE 1159, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
University of Cape Town / Faculty of Health Sciences
The Johns Hopkins Hospital


Antony Rosen Photo 2

Professor And Director At Johns Hopkins School Of Medicine

Position:
Professor and Director at Johns Hopkins School of Medicine
Location:
Baltimore, Maryland Area
Industry:
Research
Work:
Johns Hopkins School of Medicine - Professor and Director


Antony Rosen Photo 3

Citrullination Of Human Peptidylarginine Deiminase 4 (Pad-4) Regulates Its Function And Immunogenicity

US Patent:
2013010, Apr 25, 2013
Filed:
Nov 24, 2010
Appl. No.:
13/512051
Inventors:
Felipe Andrade - Timonium MD, US
Antony Rosen - Pikesville MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
C12N 9/96, A61K 38/50, A61K 45/06, G01N 33/68
US Classification:
4241851, 435188, 435 71, 435 792
Abstract:
The present invention provides peptidylarginine deiminase 4 (PAD-4) polypeptides comprising one or more citrullinated Arginine sites. In one embodiment, a PAD-4 polypeptide comprises a citrulline residue at the following sites: Arg-205, Arg-212, Arg-218, Arg-372, Arg-374, Arg-383, Arg-394, Arg-495, Arg-536, and Arg-544. The present invention also provides methods for detecting the presence of autoantibodies to citrullinated PAD-4. The methods of the present invention may also be used to qualify Rheumatoid Arthritis status in a subject. In other embodiments, the present invention provides methods for inducing tolerance to citrullinated PAD-4.


Antony Rosen Photo 4

Detection Of Auto-Antibodies To Specific Glycans As Diagnostic Tests For Autoimmune Diseases

US Patent:
2012019, Jul 26, 2012
Filed:
Aug 25, 2010
Appl. No.:
13/392202
Inventors:
Bruce Scott Bochner - Lutherville MD, US
Stephan Matthias Von Gunten - Bern, CH
Antony Rosen - Pikesville MD, US
Thomas Grader-Beck - Reisterstown MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
G01N 33/53, C40B 30/04
US Classification:
506 9, 436501, 435 792
Abstract:
The invention provides uses, methods, and kits for diagnosing an autoimmune disease, particularly scleroderma and systemic lupus erythematosus, in a subject by detecting the presence of one or more antibodies that specifically bind to one or more glycans in a subject sample.


Antony Rosen Photo 5

Compositions And Methods For Characterizing A Myopathy

US Patent:
2013004, Feb 14, 2013
Filed:
Apr 15, 2011
Appl. No.:
13/641606
Inventors:
Andrew Mammen - Baltimore MD, US
Antony Rosen - Pikesville MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
G01N 33/53, C12N 11/00, G01N 21/25
US Classification:
435 71, 435174
Abstract:
The invention provides compositions, methods, and kits diagnosing, monitoring, and otherwise characterizing a myopathy and for detecting the presence of autoantibodies in a biological sample.